GlucoTrack Inc (GCTK)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $2.43M
Last updated: Nov 16, 2026 at 4:00 PM ET
GlucoTrack Inc (GCTK) Statistics
GlucoTrack (GCTK) has a market cap of $2.43M and an enterprise value of $3.24M. Its share count is up 912.95% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 33.62% above the market cap, as debt exceeds cash.
| Market Cap | $2.43M |
|---|---|
| Enterprise Value | $3.24M |
| Close (Nov 16, 2026) | $0.19 |
Key Dates
| Last Earnings Date | Aug 14, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 99.89% over 52 weeks and trades 92.24% below its 50-day average.
| Beta (1Y) | 3.47 |
|---|---|
| 52-Week Change | -99.89% |
| 1-Month Change | -86.87% |
| 3-Month Change | -98.16% |
| 6-Month Change | -98.69% |
| 5-Year Change | -100.00% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -99.89% |
| Total Return (3Y CAGR) | -98.10% |
| Total Return (5Y CAGR) | -95.05% |
| Max Drawdown (1Y) | -99.91% |
| Max Drawdown (3Y) | -100.00% |
| Sharpe Ratio (1Y) | -3.11 |
| Correlation with SPY (1Y) | 0.22 |
| 50-Day Average | $2.45 |
| 200-Day Average | $17.78 |
| 52-Week Range | $0.75 to $207.00 |
| RSI (14 Days) | 27.7 |
| Average Volume (20 Days) | 3.68M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.46x current liabilities.
| Current Ratio | 0.46x |
|---|---|
| Quick Ratio | 0.46x |
Returns and Efficiency
Return on invested capital is -6319.21% over the last 12 months.
| Return on Assets (ROA) | -1066.69% |
|---|---|
| Return on Invested Capital (ROIC) | -6319.21% |
Scores
GCTK has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$14.00K |
| Operating Income | -$15.40M |
| Pretax Income | -$15.95M |
| Net Income | -$15.95M |
| EBITDA | -$15.38M |
| EBIT | -$15.92M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
| Cash and Equivalents | $1.12M |
|---|---|
| Total Debt | $1.94M |
| Net Debt | $816.00K |
| Net Debt Per Share | $4.89 |
| Working Capital | -$1.61M |
| Shareholder Equity | -$1.74M |
| Total Assets | $1.50M |
| Total Liabilities | $3.24M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$16.22M |
|---|---|
| FCF Per Share | -$16.02 |
| Depreciation and Amortization | $541.00K |
Trailing 12 months through Jun 30, 2026.
Dividends and Yields
GCTK does not pay a dividend.
| Buyback Yield | -11132.08% |
|---|---|
| Shareholder Yield | -11132.08% |
Stock Splits
The last split was a 1-for-2 reverse split on Oct 26, 2026.
| Last Split Date | Oct 26, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:2 |
Peer Position
Against 6 similar companies, GCTK has the lowest ROIC.
ROICPeer median -130.26%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +41.62%
| ROIC | -6319.21% vs -130.26% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs +41.62% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GCTK
What is GCTK's market cap?
GlucoTrack has a market cap of $2.43M. Its enterprise value, which adds debt and subtracts cash, is $3.24M.
How many shares of GCTK are outstanding?
GlucoTrack has 166.97K shares outstanding. The count is up 912.95% from a year earlier.
Does GCTK pay a dividend?
No. GlucoTrack does not pay a dividend.
How much debt does GCTK have?
GlucoTrack has $1.94M of total debt and $1.12M of cash and equivalents, a net debt position of $816.00K.
GCTK pages: Overview, Charting, Financials, Statistics, Competitors